Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Kolata G. How bright promise in cancer testing fell apart. The New York Times. 2011.
http://www.nytimes.com/2011/07/08/health/research/08genes.html?_r=0
.
2. Baggerly KA, Coombes KR. Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology. Ann Appl Stat. 2009;3:1309–34.
3. Martins FC, Santiago I, Trinh A, Xian J, Guo A, Sayal K, et al. Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier. Genome Biol. 2014;15:526.
4. Schwarz RF, Ng CKY, Cooke SL, Newman S, Temple J, Piskorz AM, et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLoS Med. 2015;12:1001789.
5. Castro MAA, Fletcher M, Markowetz F, Meyer K. Gene expression data from breast cancer cells under FGFR2 signalling perturbation. BioConductor Experimental Package.
http://bioconductor.org/packages/release/data/experiment/html/Fletcher2013a.html
. Accessed 27 Nov 2015.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献